• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of aemPermissionsJournals.ASM.orgJournalAEM ArticleJournal InfoAuthorsReviewers
Appl Environ Microbiol. Jan 1997; 63(1): 44–49.
PMCID: PMC168300

Antimycoplasma properties and application in cell culture of surfactin, a lipopeptide antibiotic from Bacillus subtilis.

Abstract

Surfactin, a cyclic lipopeptide antibiotic and biosurfactant produced by Bacillus subtilis, is well-known for its interactions with artificial and biomembrane systems (e.g., bacterial protoplasts or enveloped viruses). To assess the applicability of this antiviral and antibacterial drug, we determined the cytotoxicity of surfactin with a 50% cytotoxic concentration of 30 to 64 microM for a variety of human and animal cell lines in vitro. Concomitantly, we observed an improvement in proliferation rates and changes in the morphology of mycoplasma-contaminated mammalian cells after treatment with this drug. A single treatment over one passage led to complete removal of viable Mycoplasma hyorhinis cells from various adherent cell lines, and Mycoplasma orale was removed from nonadherent human T-lymphoid cell lines by double treatment. This effect was monitored by a DNA fluorescence test, an enzyme-linked immunosorbent assay, and two different PCR methods. Disintegration of the mycoplasma membranes as observed by electron microscopy indicated the mode of action of surfactin. Disintegration is obviously due to a physicochemical interaction of the membrane-active surfactant with the outer part of the lipid membrane bilayer, which causes permeability changes and at higher concentrations leads finally to disintegration of the mycoplasma membrane system by a detergent effect. The low cytotoxicity of surfactin for mammalian cells permits specific inactivation of mycoplasmas without significant deleterious effects on cell metabolism and the proliferation rate in cell culture. These results were used to develop a fast and simple method for complete and permanent inactivation of mycoplasmas in mammalian monolayer and suspension cell cultures.

Full Text

The Full Text of this article is available as a PDF (490K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Baumgart F, Kluge B, Ullrich C, Vater J, Ziessow D. Identification of amino acid substitutions in the lipopeptide surfactin using 2D NMR spectroscopy. Biochem Biophys Res Commun. 1991 Jun 28;177(3):998–1005. [PubMed]
  • Bernheimer AW, Avigad LS. Nature and properties of a cytolytic agent produced by Bacillus subtilis. J Gen Microbiol. 1970 Jun;61(3):361–369. [PubMed]
  • Blanchard A, Montagnier L. AIDS-associated mycoplasmas. Annu Rev Microbiol. 1994;48:687–712. [PubMed]
  • Chowdhury MI, Munakata T, Koyanagi Y, Arai S, Yamamoto N. Mycoplasma stimulates HIV-1 expression from acutely- and dormantly-infected promonocyte/monoblastoid cell lines. Arch Virol. 1994;139(3-4):431–438. [PubMed]
  • Fleckenstein E, Uphoff CC, Drexler HG. Effective treatment of mycoplasma contamination in cell lines with enrofloxacin (Baytril). Leukemia. 1994 Aug;8(8):1424–1434. [PubMed]
  • Flick DA, Gifford GE. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J Immunol Methods. 1984 Mar 30;68(1-2):167–175. [PubMed]
  • Gelderblom HR, Hausmann EH, Ozel M, Pauli G, Koch MA. Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology. 1987 Jan;156(1):171–176. [PubMed]
  • Hay RJ, Macy ML, Chen TR. Mycoplasma infection of cultured cells. Nature. 1989 Jun 8;339(6224):487–488. [PubMed]
  • Hosono K, Suzuki H. Acylpeptides, the inhibitors of cyclic adenosine 3',5'-monophosphate phosphodiesterase. III. Inhibition of cyclic AMP phosphodiesterase. J Antibiot (Tokyo) 1983 Jun;36(6):679–683. [PubMed]
  • Hosono K, Suzuki H. Morphological transformation of Chinese hamster cells by acylpeptides, inhibitors of cAMP phosphodiesterase, produced by Bacillus subtilis. J Biol Chem. 1985 Sep 15;260(20):11252–11255. [PubMed]
  • Kameda Y, Oira S, Matsui K, Kanatomo S, Hase T. Antitumor activity of bacillus natto. V. Isolation and characterization of surfactin in the culture medium of Bacillus natto KMD 2311. Chem Pharm Bull (Tokyo) 1974 Apr;22(4):938–944. [PubMed]
  • Lin SC, Minton MA, Sharma MM, Georgiou G. Structural and immunological characterization of a biosurfactant produced by Bacillus licheniformis JF-2. Appl Environ Microbiol. 1994 Jan;60(1):31–38. [PMC free article] [PubMed]
  • Maget-Dana R, Ptak M. Interactions of surfactin with membrane models. Biophys J. 1995 May;68(5):1937–1943. [PMC free article] [PubMed]
  • Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983 Dec 16;65(1-2):55–63. [PubMed]
  • Razin S. The mycoplasmas. Microbiol Rev. 1978 Jun;42(2):414–470. [PMC free article] [PubMed]
  • Rottem S. Membrane lipids of mycoplasmas. Biochim Biophys Acta. 1980 May 27;604(1):65–90. [PubMed]
  • Russell WC, Newman C, Williamson DH. A simple cytochemical technique for demonstration of DNA in cells infected with mycoplasmas and viruses. Nature. 1975 Feb 6;253(5491):461–462. [PubMed]
  • Schmidt J, Erfle V. Elimination of mycoplasmas from cell cultures and establishment of mycoplasma-free cell lines. Exp Cell Res. 1984 Jun;152(2):565–570. [PubMed]
  • Sheppard JD, Jumarie C, Cooper DG, Laprade R. Ionic channels induced by surfactin in planar lipid bilayer membranes. Biochim Biophys Acta. 1991 Apr 26;1064(1):13–23. [PubMed]
  • Toraya T, Maoka T, Tsuji H, Kobayashi M. Purification and structural determination of an inhibitor of starfish oocyte maturation from a Bacillus species. Appl Environ Microbiol. 1995 May;61(5):1799–1804. [PMC free article] [PubMed]
  • Tsukagoshi N, Tamura G, Arima K. A novel protoplast-bursting factor (surfactin) obtained from bacillus subtilis IAM 1213. II. The interaction of surfactin with bacterial membranes and lipids. Biochim Biophys Acta. 1970;196(2):211–214. [PubMed]
  • Uphoff CC, Gignac SM, Drexler HG. Mycoplasma contamination in human leukemia cell lines. II. Elimination with various antibiotics. J Immunol Methods. 1992 Apr 27;149(1):55–62. [PubMed]
  • van Kuppeveld FJ, Johansson KE, Galama JM, Kissing J, Bölske G, van der Logt JT, Melchers WJ. Detection of mycoplasma contamination in cell cultures by a mycoplasma group-specific PCR. Appl Environ Microbiol. 1994 Jan;60(1):149–152. [PMC free article] [PubMed]

Articles from Applied and Environmental Microbiology are provided here courtesy of American Society for Microbiology (ASM)

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...